MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EL AZHARY, R.
Right arrow Articles by MANNERING, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by EL AZHARY, R.
Right arrow Articles by MANNERING, G. J.

Molecular Pharmacology, Vol 17, 395-399, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Effect of Interferon Inducing Agents (Polyriboinosinic Acid· Polyribocytidylic Acid and Tilorone) on the Heme Turnover of Hepatic Cytochrome P-450

ROKEA EL AZHARY 1, KENNETH W. RENTON 1, and GILBERT J. MANNERING 1

1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455

The cytochrome P-450 and heme contents of microsomes are lowered markedly in livers of rats treated with the interferon inducing agents, tilorone and poly(rI·rC) (polyriboinosinic acid·polyribocytidylic acid). The turnover of cytochrome P-450 heme was studied to determine whether the loss of cytochrome P-450 and heme was due to a decreased synthesis or to an increased degradation of the hemoprotein. Two populations of cytochrome P-450 exist in hepatic microsomes, one with a relatively short and one with a long half-life. The half-lives of cytochrome P-450 heme in control animals were determined to be about 8 and 40 h. After the administration of tilorone or poly(rI·rC), the half-life of the short-lived cytochrome P-450 was lowered to about 5 h but that of the long-lived cytochrome P-450 was not changed. These interferon inducing agents produced no appreciable decrease in the incorporation of the radioactivity of administered ALA-3,5-3H or glycine-2-14C into the heme of cytochrome P-420 derived from cytochrome P-450. However, a rise in specific activity was observed 10 and 24 h after the administration of poly(rI·rC) and tilorone, respectively. This increase in specific activity is interpreted to mean that interferon inducing agents increase the rate of breakdown of preformed cytochrome P-450 heme and that some of this is replaced by newly synthesized labeled heme. It is concluded from these results that poly(rI·rC) and tilorone lower the concentration of hepatic hemoproteins by increasing their degradation rather than by depressing their synthesis.

Submitted on January 2, 1979
Accepted on November 19, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics